Literature DB >> 20801501

Ivabradine in heart failure--no paradigm SHIFT…yet.

John R Teerlink1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20801501     DOI： 10.1016/S0140-6736(10)61314-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  HCN channels in the heart: lessons from mouse mutants.

Authors:  S Herrmann; F Hofmann; J Stieber; A Ludwig
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Heart failure: A SHIFT from ion channels to clinical practice.

Authors:  Cesare M Terracciano; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

3.  Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.

Authors:  S Suffredini; F Stillitano; L Comini; M Bouly; S Brogioni; C Ceconi; R Ferrari; A Mugelli; E Cerbai
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 4.  Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges.

Authors:  Catherine N Marti; Gregg C Fonarow; Stefan D Anker; Clyde Yancy; Muthiah Vaduganathan; Stephen J Greene; Ali Ahmed; James L Januzzi; Mihai Gheorghiade; Gerasimos Filippatos; Javed Butler
Journal:  Eur J Heart Fail       Date:  2018-12-10       Impact factor: 15.534

5.  Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.

Authors:  Alexis Bosman; Laura Sartiani; Valentina Spinelli; Martina Del Lungo; Francesca Stillitano; Daniele Nosi; Alessandro Mugelli; Elisabetta Cerbai; Marisa Jaconi
Journal:  Stem Cells Dev       Date:  2013-02-27       Impact factor: 3.272

Review 6.  Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure.

Authors:  Gordon F Rushworth; Philippe Lambrakis; Stephen J Leslie
Journal:  Ther Adv Drug Saf       Date:  2011-02

7.  Association between systolic ejection time and outcomes in heart failure by ejection fraction.

Authors:  Priyesh A Patel; Andrew P Ambrosy; Matthew Phelan; Fawaz Alenezi; Karen Chiswell; Melissa K Van Dyke; Jennifer Tomfohr; Narimon Honarpour; Eric J Velazquez
Journal:  Eur J Heart Fail       Date:  2019-12-21       Impact factor: 15.534

Review 8.  HCN channels--modulators of cardiac and neuronal excitability.

Authors:  Stefan Herrmann; Sabine Schnorr; Andreas Ludwig
Journal:  Int J Mol Sci       Date:  2015-01-08       Impact factor: 5.923

9.  Do general practitioners follow treatment recommendations from guidelines in their decisions on heart failure management? A cross-sectional study.

Authors:  Maartje H J Swennen; Frans H Rutten; Cor J Kalkman; Yolanda van der Graaf; Alfred P E Sachs; Geert J M G van der Heijden
Journal:  BMJ Open       Date:  2013-09-16       Impact factor: 2.692

Review 10.  Ivabradine, coronary artery disease, and heart failure: beyond rhythm control.

Authors:  Pietro Scicchitano; Francesca Cortese; Gabriella Ricci; Santa Carbonara; Michele Moncelli; Massimo Iacoviello; Annagrazia Cecere; Michele Gesualdo; Annapaola Zito; Pasquale Caldarola; Domenico Scrutinio; Rocco Lagioia; Graziano Riccioni; Marco Matteo Ciccone
Journal:  Drug Des Devel Ther       Date:  2014-06-03       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.